J Health Care Poor Underserved. 2022;33(1):5-19. doi: 10.1353/hpu.2022.0003.
While Black men face a significant cancer risk burden in the United States, confronting complex historical and social issues such as racism and discrimination undermines care. This study explored associations between perceived racism, prostate screening rates, and shared medical discussions.
We performed data analysis of merged Behavioral Risk Factor Surveillance System (BRFSS) survey data. Data were limited to Black and White men. We used propensity score analysis to assess the race-associated effects on outcomes.
Black men were less likely than White men to receive discussions of both prostate-specific antigen (PSA) screening advantages χ2(4.54), p < .05 and disadvantages χ2(41.62), p < .001. The effects of perceived racism and its interaction with race were statistically non-significant for all PSA outcomes.
Compared with their White counterparts, Black men were significantly less likely to be advised of potential PSA screening advantages and harms. This inequity in health care delivery has implications concerning disease prevention and informed decision-making.
尽管美国的黑人男性面临着巨大的癌症风险负担，但面临着种族主义和歧视等复杂的历史和社会问题，这削弱了他们的医疗保健。本研究探讨了感知到的种族主义、前列腺筛查率和共同的医疗讨论之间的关联。
我们对合并的行为风险因素监测系统（BRFSS）调查数据进行了数据分析。数据仅限于黑人和白人男性。我们使用倾向评分分析来评估种族对结果的影响。
与白人男性相比，黑人男性接受前列腺特异性抗原（PSA）筛查优势讨论的可能性较小 χ2（4.54），p <.05 和劣势 χ2（41.62），p <.001。对于所有 PSA 结果，感知到的种族主义及其与种族的相互作用的影响均无统计学意义。
与白人男性相比，黑人男性接受潜在 PSA 筛查优势和危害咨询的可能性明显较小。这种医疗保健提供方面的不平等会对疾病预防和知情决策产生影响。
